Quantcast
Last updated on April 23, 2014 at 12:31 EDT

Latest Implanted cardiac resynchronization device Stories

2014-04-15 16:28:34

NATICK, Mass., April 15, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include the DYNAGEN(TM) MINI and INOGEN(TM) MINI ICDs, as well as the DYNAGEN(TM) X4 and INOGEN(TM) X4 CRT-Ds. The X4 line of quadripolar CRT-Ds offers 70 percent more pacing options to address high capture thresholds and phrenic nerve...

2014-04-02 16:30:55

LONDON, April 2, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: MediPoint: Cardiac Rhythm Management - APAC Analysis and Market Forecasts MediPoint: Cardiac Rhythm Management - APAC Analysis and Market Forecasts SummaryCardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of...

2014-04-02 16:30:42

LONDON, April 2, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: MediPoint: Cardiac Rhythm Management - EU Analysis and Market Forecasts MediPoint: Cardiac Rhythm Management - EU Analysis and Market Forecasts SummaryCardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of which...

2014-04-01 12:33:31

LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:MediPoint: Cardiac Rhythm Management - US Analysis and Market ForecastsMediPoint: Cardiac Rhythm Management - US Analysis and Market ForecastsSummaryCardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of...

2014-04-01 12:32:58

LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:MediPoint: Cardiac Rhythm Management - Global Analysis and Market ForecastsMediPoint: Cardiac Rhythm Management - Global Analysis and Market ForecastsSummaryCardiac rhythm management (CRM) comprises any method of treatment aimed at regulating the heart's rhythm, including medication, medical devices, and occasionally surgery. There can be a number of reasons why CRM is needed, all of...

2014-03-30 12:20:07

MADIT-CRT Long-Term Follow-up Results Presented at the American College of Cardiology and Published in the New England Journal of Medicine NATICK, Mass., March 30, 2014 /PRNewswire/ -- In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's (NYSE: BSX) exclusively sponsored and landmark Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy (MADIT-CRT) study...

2013-12-17 08:29:25

NATICK, Mass., Dec. 17, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval of its X4 line of quadripolar CRT-D systems, including the AUTOGEN(TM) X4, DYNAGEN(TM) X4, and INOGEN(TM) X4 cardiac resynchronization therapy defibrillators (CRT-Ds), a suite of ACUITY(TM) X4 quadripolar LV leads and the ACUITY(TM) PRO lead delivery system. The company's latest devices to treat heart failure and sudden cardiac arrest are designed to advance patient...

2013-10-21 20:21:24

DUBLIN, Ireland, October 21, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/mbj4tm/global_cardiac) has announced the addition of the "Global Cardiac Resynchronization Therapy (CRT) Devices - Market Growth Analysis, 2009-2015" [http://www.researchandmarkets.com/research/mbj4tm/global_cardiac ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global Cardiac CRT devices market is...

2013-10-08 20:22:24

University of Pittsburgh independent study of contemporary heart failure devices highlights industry-leading Boston Scientific battery longevity NATICK, Mass., Oct. 8, 2013 /PRNewswire/ -- An independent and first-of-its-kind study from the University of Pittsburgh Medical Center, published online this week in EP EuroPace, shows there are significant differences in battery longevity between contemporary cardiac resynchronization therapy defibrillator (CRT-D) devices, and that the...

2013-09-04 12:33:34

DUBLIN, September 4, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/z565vj/global_cardiac) has announced the addition of the "Global Cardiac Rhythm Management (CRM) Devices - Market Growth Analysis, 2009-2015" [http://www.researchandmarkets.com/research/z565vj/global_cardiac ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The Global Cardiac Rhythm Management Devices (CRM) market...